Rapid Response: How mission fuels risk-taking, with Illumina CEO Francis deSouza

Facing off with the FTC isn't for the timid. But when your mission and your business model are aligned, the hard decisions – about risk, about investment, about priorities – become clearer. Francis deSouza is CEO of Illumina, the world’s dominant maker of gene sequencing technology. After playing a key role in the creation of Covid vaccines, Illumina is trying to acquire a company with a breakthrough cancer screening test, over the FTC's objections. DeSouza offers a personal reflection on the lessons and reality of grappling with regulators, highlighting levers that can help to accelerate scale. What underscores his entrepreneurial efforts is a passion for Illumina’s mission: improving human health by unlocking the power of the genome. Read a transcript of this interview at: mastersofscale.com Subscribe to the Masters of Scale weekly newsletter: https://mastersofscale.com/subscribe See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Om Podcasten

Award-winning business advice from Silicon Valley and beyond. Iconic CEOs, from Nike to Netflix, Starbucks to Slack, share the strategies that helped them grow from startups into global brands — and to weather crisis when it strikes. On each episode of our classic format, founding host Reid Hoffman — LinkedIn cofounder, Greylock partner and legendary Silicon Valley investor — and a stellar lineup of guest hosts prove unconventional theories about how businesses scale. Guests share their stories of entrepreneurship, leadership, strategy, management, fundraising. You’ll hear the human journey, too — failures, setbacks, learnings. From our Rapid Response format, you can expect real-time wisdom from business leaders in fast-changing situations. Hosted by Bob Safian, past editor-in-chief of Fast Company, these episodes tackle crisis response, rebuilding, diversity & inclusion, leadership change and much more.